BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CASL - Canadian Association for the Study of the Liver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CASL - Canadian Association for the Study of the Liver
X-ORIGINAL-URL:https://hepatology.ca
X-WR-CALDESC:Events for CASL - Canadian Association for the Study of the Liver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250318T080000
DTEND;TZID=UTC:20250318T170000
DTSTAMP:20260416T204409
CREATED:20241209T215611Z
LAST-MODIFIED:20241209T215611Z
UID:4552-1742284800-1742317200@hepatology.ca
SUMMARY:North American Viral Hepatitis Elimination Summit
DESCRIPTION:The North American Viral Hepatitis Elimination Summit is a collaborative event organized by the American Association for the Study of Liver Diseases (AASLD)\, the Canadian Association for the Study of the Liver (CASL)\, and the Asociación Mexicana de Hepatología (AMH). This summit aims to foster collaboration\, exchange ideas\, and enhance knowledge translation among healthcare professionals across North America. \nThe summit will feature presentations and workshops led by public health and medical experts\, focusing on strategies for viral hepatitis prevention\, screening\, diagnosis\, and treatment. Attendees will learn about the latest innovations and how they can be applied to achieve the goal of viral hepatitis elimination and reduce liver complications\, including liver cancer. \nFor more details\, visit the official summit page.
URL:https://hepatology.ca/event/north-american-viral-hepatitis-elimination-summit/
CATEGORIES:CASL Events,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250228
DTEND;VALUE=DATE:20250303
DTSTAMP:20260416T204409
CREATED:20240926T165010Z
LAST-MODIFIED:20241120T165518Z
UID:4405-1740700800-1740959999@hepatology.ca
SUMMARY:Joint CDDW™-CLM Conference 2025
DESCRIPTION:The Joint CDDW™-CLM Conference 2025 is the premier meeting for all members of the Canadian gastroenterology and hepatology communities\, including trainees\, nurses\, and researchers with an interest in liver and gastroenterology. We are delighted to invite you to the Joint 2025 Canadian Digestive Diseases Week™ and Canadian Liver Meeting Conference\, taking place from February 28 to March 2\, 2025\, in Québec City\, Quebec. This conference is a collaborative effort between the Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver\, along with their affiliates: the Canadian Network on Hepatitis C\, Canadian NASH Network\, Canadian Association of Hepatology Nurses\, and TRIANGLE.
URL:https://hepatology.ca/event/joint-cddw-clm-conference-2025/
LOCATION:Quebec City
CATEGORIES:CASL Events,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241211T200000
DTEND;TZID=America/Toronto:20241211T210000
DTSTAMP:20260416T204410
CREATED:20241029T193423Z
LAST-MODIFIED:20241030T143654Z
UID:4453-1733947200-1733950800@hepatology.ca
SUMMARY:CASL Educational Webinar Series: Hepatic Encephalopathy
DESCRIPTION:We are thrilled to invite you to an exclusive webinar on Hepatic Encephalopathy (HE)\, hosted by CASL with the generous support of Lupin. This session will feature leading experts discussing the latest advancements in diagnosing\, managing\, and treating HE. Register here to join. \nTitle: CASL Educational Webinar Series: Hepatic Encephalopathy \nDate: Wednesday\, December 11 at 8:00 pm ET \nFormat: Zoom webinar \nModerator: Chris Rose \nSpeakers: \n\nStephen Congly\, Canada\nDebbie Shawcross\, UK\n\n  \nSchedule: \n8:00 – 8:05 pm – Introduction – Chris Rose \n8:05 – 8:25 pm – Presentation #1 – HE management review & Post-TIPS HE Management – Stephen Congly \n8:25 – 8:45 pm – Presentation #2 – The Role of Infection in HE – Debbie Shawcross \n8:45 – 9:00 pm – Q&A and Panel Discussion   \n  \nSupported by unrestricted educational grant from: \n \n  \nREGISTER HERE \n 
URL:https://hepatology.ca/event/casl-educational-webinar-series-hepatic-encephalopathy/
LOCATION:Online
CATEGORIES:CASL Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20241128T180000
DTEND;TZID=America/Vancouver:20241128T193000
DTSTAMP:20260416T204410
CREATED:20241004T135938Z
LAST-MODIFIED:20241004T135938Z
UID:4427-1732816800-1732822200@hepatology.ca
SUMMARY:SHINE - Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies
DESCRIPTION:You are cordially invited to SHINE – Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies. A multidisciplinary virtual case-based discussion comprised of leading experts across Western Canada. \nThurs Nov 28 2024\, 6-730 PST | 7-8:30 MST | 8-9:30 CST \n \n  \nPanelists \n\nDr Michael Bleszynski\, HPB Surgeon at Vancouver General Hospital – Vancouver\nDr Mayur Brahmania\, Hepatologist at University of Calgary and CASL’s Education Committee Co-Chair – Calgary\nDr Howard Lim\, Medical Oncologist at BC Cancer Agency – Vancouver\nDr Dave Liu\, Interventional Radiologist at University of British Columbia – Vancouver\nDr Maged Nashed\, Radiation Oncologist at University of Manitoba – Winnipeg\nDr Jennifer Spratlin\, Medical Oncologist at Cross Cancer Institute – Edmonton\nDr Vincent Tam\, Medical Oncologist at Tom Baker Cancer Centre – Calgary\n\nObjectives \n\nUnderstand the current treatment landscape of intermediate HCC.\nAnalyze the emerging role of systemic therapies in TACE/TARE-eligible intermediate HCC.\nDiscuss the use of systemic therapy prior to liver transplant for intermediate stage HCC\npatients.\nExamine future directions and emerging therapies/treatment strategies in intermediate HCC.\n\nPlease RSVP here: https://forms.office.com/e/7qf5GTXZXu
URL:https://hepatology.ca/event/shine-systemic-hepatocellular-carcinoma-incorporating-new-emerging-therapies/
LOCATION:Online
CATEGORIES:Endorsed by CASL,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241115
DTEND;VALUE=DATE:20241120
DTSTAMP:20260416T204410
CREATED:20241029T132127Z
LAST-MODIFIED:20241113T000617Z
UID:4421-1731628800-1732060799@hepatology.ca
SUMMARY:The 75th Liver Meeting | AASLD
DESCRIPTION:The 75th Liver Meeting is a global gathering you won’t want to miss! This is your opportunity to engage with other international partners dedicated to advancing liver health at #TLM24\, Nov. 15-19 in San Diego! For over seven decades\, this gathering has been the premier event for hepatology professionals worldwide to collaborate and share cutting-edge expertise. It’s not too late to register: https://www.aasld.org/the-liver-meeting
URL:https://hepatology.ca/event/the-75th-liver-meeting/
CATEGORIES:Endorsed by CASL,In-Person,Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241019T141500
DTEND;TZID=UTC:20241020T163000
DTSTAMP:20260416T204410
CREATED:20240608T163050Z
LAST-MODIFIED:20240608T163109Z
UID:3884-1729347300-1729441800@hepatology.ca
SUMMARY:CASL Single Topic Conference on HCC
DESCRIPTION:CASL is pleased to announce the Canadian Association for the Study of the Liver (CASL) Single Topic Conference on HCC. This prestigious event\, dedicated to the exploration of advancements in liver cancer research and treatment\, will be held in conjunction with the International Liver Cancer Association (ILCA) at the Hilton Toronto – 145 Richmond Street West in Toronto on October 19th and 20th\, 2024. \nMore information on the program\, registration and other details are available on the conference website.
URL:https://hepatology.ca/event/casl-single-topic-conference-on-hcc/
LOCATION:Hilton Toronto\, 145 Richmond Street West\, Toronto\, Ontario\, Canada
CATEGORIES:CASL Events,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241018T110000
DTEND;TZID=America/Halifax:20241019T170000
DTSTAMP:20260416T204410
CREATED:20240608T164853Z
LAST-MODIFIED:20240608T164937Z
UID:3892-1729249200-1729357200@hepatology.ca
SUMMARY:ILCA 2024 Annual Conference
DESCRIPTION:The 18th edition of the ILCA Annual Conference will be held in conjunction with the Canadian Association for the Study of the Liver (CASL) Single Topic Conference on HCC on 17-19 October in Toronto\, Canada\, promising yet another enriching and impactful gathering for the liver cancer community. \nConnect with inspiring liver cancer specialists through exceptional education and pioneering insights. \nJoin us in Toronto to unite minds and transform the landscape of liver cancer treatment and care.
URL:https://hepatology.ca/event/ilca-2024-annual-conference/
LOCATION:Hilton Toronto\, 145 Richmond Street West\, Toronto\, Ontario\, Canada
CATEGORIES:Endorsed by CASL
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241004
DTEND;VALUE=DATE:20241006
DTSTAMP:20260416T204410
CREATED:20240716T145549Z
LAST-MODIFIED:20240716T145549Z
UID:4134-1728000000-1728172799@hepatology.ca
SUMMARY:Canadian Multidisciplinary Hepatobiliary Cancer Conference
DESCRIPTION:The 3rd CANADIAN MULTIDISCIPLINARY HEPATOBILIARY CANCER CONFERENCE (CMHCC) is taking place on Friday October 4 and Saturday October 5th\, 2024 at the Omni King Edward Hotel in Toronto\, Ontario\, Canada. \n \nThis informative conference provides a unique opportunity for attendees to participate in presentations from international experts in the field of Multidisciplinary Hepatobiliary Cancer. The scope of this meeting will highlight both recent research findings elucidating the pathophysiology of these diverse diseases\, as well as changes in therapeutic advances that have had a large impact in the management of patients. \nFor more information\, please visit CMHCC 2024 website.
URL:https://hepatology.ca/event/canadian-multidisciplinary-hepatobiliary-cancer-conference/
LOCATION:Toronto\, Toronto\, Canada
CATEGORIES:In-Person,Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240919
DTEND;VALUE=DATE:20240922
DTSTAMP:20260416T204410
CREATED:20240218T205721Z
LAST-MODIFIED:20240218T205816Z
UID:3494-1726704000-1726963199@hepatology.ca
SUMMARY:Conference on Liver Disease in Africa (COLDA) 2024
DESCRIPTION:Co-organized by SOLDA and Academic Medical Education in close collaboration with regional societies\, COLDA 2024 aims at empowering healthcare professionals (HCPs) to diagnose\, prevent\, treat\, and achieve a cure for liver diseases for the benefit of patients in Africa. \n \nThis being the 7th COLDA\, we continue to cultivate a platform that provides a unique opportunity for clinicians\, researchers\, policymakers\, industry representatives\, and other healthcare professionals in the African region. Together with support from an international community of experts\, they will exchange knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context. \nWe aspire to provide you with a highly scientific and educational abstract-driven conference consisting of keynote speeches\, state-of-the-art lectures\, oral and poster abstract presentations\, roundtable discussions\, and debates with ample time for discussion. \nWe are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone will have an exceptional opportunity to share and acquire knowledge\, and experience a wide spectrum of topics related to liver disease.
URL:https://hepatology.ca/event/conference-on-liver-disease-in-africa-colda-2024/
LOCATION:Cairo\, Egypt
CATEGORIES:In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240913
DTEND;VALUE=DATE:20240915
DTSTAMP:20260416T204410
CREATED:20240315T141833Z
LAST-MODIFIED:20240508T194138Z
UID:3513-1726185600-1726358399@hepatology.ca
SUMMARY:Advancing DEI in Transplantation: A Global Perspective
DESCRIPTION:Join us for the inaugural Advancing Diversity\, Equity & Inclusion in Transplantation: A Global Perspective conference\, hosted by the Ajmera Transplant Center in Toronto\, September 13 and 14. This groundbreaking event brings together International Transplant Leaders\, clinicians\, surgeons\, nurses\, researchers\, policy makers\, and representatives from academic and community-based organizations. \n \nKey Highlights: \n\nUnderstanding DEI Challenges: Explore the critical challenges faced by transplant providers and patients in achieving Diversity\, Equity\, and Inclusion (DEI) across organ groups.\nPatient-Centric Approach: Our focus centers on patients and caregivers\, ensuring their voices are heard and their needs addressed.\nNotable Speakers:\n\nNancy Ascher: A renowned transplant surgeon and advocate for equity in healthcare.\nNorah Terrault: An expert in liver transplantation and a champion for diversity and inclusion.\n\n\n\nAbstract Submission Open! Submit your abstract for poster presentation at the conference. Abstract submission deadline: May 1\, 2024. \nDon’t miss this unique opportunity to be part of a global dialogue on advancing DEI in transplantation. Learn more and register at deiintransplant.com.
URL:https://hepatology.ca/event/advancing-dei-in-transplantation-a-global-perspective/
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240911
DTEND;VALUE=DATE:20240916
DTSTAMP:20260416T204410
CREATED:20240527T134608Z
LAST-MODIFIED:20240527T134723Z
UID:3634-1726012800-1726444799@hepatology.ca
SUMMARY:2024 International HBV Meeting
DESCRIPTION:The 2024 International HBV Meeting is the preeminent global conference on Hepatitis B research set to take place September 11-15\, 2024 in Chicago\, USA. This event brings together scientists\, physicians\, and public health professionals from around the world who are at the forefront of Hepatitis B research. \n \nHear from the leading experts in the field of Hepatitis B research. Engage in high-level discussions on the latest advancements in HBV research. Connect with peers\, mentors\, and leaders in the field. \nJoin us for this exciting event! Registration for the 2024 International HBV Meeting is now open. Click here to register.
URL:https://hepatology.ca/event/2024-international-hbv-meeting/
LOCATION:Chicago\, IL\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240605
DTEND;VALUE=DATE:20240609
DTSTAMP:20260416T204410
CREATED:20240218T203446Z
LAST-MODIFIED:20240218T203523Z
UID:3484-1717545600-1717891199@hepatology.ca
SUMMARY:EASL Congress 2024
DESCRIPTION:Welcome to EASL Congress 2024\, a gathering that unites the world of hepatology\, taking place from 5-8 June 2024 in Milan\, Italy\, as well as online. \n \nBringing together over 7\,000 professionals\, including clinicians\, researchers\, allied health professionals\, patient representatives\, and industry professionals\, the EASL Congress stands out as Europe’s largest event in this domain. \nFour days of congress full of interactivity and hands-on learning sessions from world-class faculty. Excellent opportunities for the liver community to present their research\, network and interact face-to-face with the greatest minds in hepatology.
URL:https://hepatology.ca/event/easl-congress-2024/
LOCATION:Allianz MiCo\, Milan\, Italy\, Allianz MiCo\, Milan\, Italy
CATEGORIES:In-Person,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240509T080000
DTEND;TZID=UTC:20240509T170000
DTSTAMP:20260416T204410
CREATED:20240428T160326Z
LAST-MODIFIED:20240508T194153Z
UID:3553-1715241600-1715274000@hepatology.ca
SUMMARY:Canadian Viral Hepatitis Elimination Day
DESCRIPTION:On Thursday\, May 9\, 2024\, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada\, CanHepC\, CanHepB\, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa. \n#CanHepDay24  #HepCantWait \nThank you to our many members and allies who are helping amplify our call for the federal government\, as well as each province and territory\, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030. \nFIVE FEDERAL ASKS \nIn 2016\, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories\, there are five key things the federal government can do now. \n1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.\nAn updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan. \n2. Testing: Update hepatitis C screening guidelines to be evidence-based\, develop evidence-based screening guidelines for hepatitis B\, and start offering free\, voluntary STBBI testing and linkage to care for all immigrants and newcomers.\nCanada’s hepatitis C screening guidelines recommend only screening people with certain risk factors\, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all\, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis. \n3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.\nHepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment\, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.\n​\n4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.\nHepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12\, which have a vaccination rate of ~70%\, missing the 90% WHO target. \n5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.\nIn order to measure our progress in viral hepatitis elimination\, we need reliable\, fulsome data about how many people are affected. \n\n\n\n\n\n\nSocial Media Graphics for Sharing\n\n\n\n\n\n\nThese graphics can be shared on social media with your own message and the hashtags #HepCantWait and #CanHepDay24.\n\n \n\n\nClick on the image to save it\n \n\nClick on the image to save it
URL:https://hepatology.ca/event/canadian-viral-hepatitis-elimination-day/
LOCATION:Ottawa\, Canada
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240503
DTEND;VALUE=DATE:20240505
DTSTAMP:20260416T204410
CREATED:20240218T204323Z
LAST-MODIFIED:20240218T204323Z
UID:3488-1714694400-1714867199@hepatology.ca
SUMMARY:Innovations in SLD Think-Tank 2024
DESCRIPTION:This 2-day program will provide an interactive platform for endocrinologists\, gastroenterologist hepatologists\, primary care physicians\, and associated health care professionals (PAs\, nurses) working in the field of SLD. Outmost goal is to allow knowledge exchange on MASLD beyond the hepatology arena and among all levels of expertise. \n \nThe new format will employ the Wilton Park style in which we intend to have panel discussions around hot topics in order to generate ideas and provide insights and recommendations: \n\nBridging the Diagnostics Gap\nPrevention is the ‘Cure’ Hidden in Plain Sight\nThe Future of Treatments Now\nMaking Ready Our World Unready\nTargeting Investments for Social and Economic Returns\nthe Role of Social Media in MASLD Education\nOpen Science Session on MASLD\n\nEach of the topics will be introduced by a short lecture highlighting the issue and kick-starting the discussion. After a focused discussion among the panel members\, the discussion is opened to the audience ensuring an informal and interactive setting to discuss audience-proposed topics. \nRegister for SLD Think-Tank 2024 \nIn addition\, the SLD Think-Tank will accept abstract submissions and look forward to inviting the key contributors to take part in the relevant panel discussions. \nAbstract Deadline: Friday\, 1 March 2024 at 23:59 CET \nAbstract Submission Link: https://virology.eventsair.com/sld2024/abstracts \n \n 
URL:https://hepatology.ca/event/innovations-in-sld-think-tank-2024/
CATEGORIES:In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20240419T100000
DTEND;TZID=Europe/Helsinki:20240419T113000
DTSTAMP:20260416T204410
CREATED:20240328T174114Z
LAST-MODIFIED:20240328T174352Z
UID:3533-1713520800-1713526200@hepatology.ca
SUMMARY:World Liver Awareness Day Webinar
DESCRIPTION:SOLDA is proud to present World Liver Awareness Day Webinar\, a 90-minute webinar focusing on challenges and solutions for liver disease in Africa. \nThe 90-minute program takes place on World Liver Day – 19 April 2024 – and showcases presentations from leading experts from the five African regions. The scientific program focuses on regionally prevalent and emerging liver diseases and special emphasis will be placed on ensuring the voices of those with lived experiences will be heard. \n \n10:00 AM CAT / SAST\nWHA – Patient Advocacy Group | The “Lost Voice” of the Patient Community\nDanjuma K. Adda\, MPH\, FIMS\, Dip-IMS\, World Hepatitis Alliance (WHA)\, Nigeria\n \n10:10 AM CAT / SAST\nEastern Africa | Viral Hepatitis (Delivery of Care Models)\nMercy Nyakowa\, MD National AIDS and STI Control Program (NASCOP)\, Ministry of Health\, Kenya\nHailemichael Desalegn Mekonnen\, MD\, PhD\, St. Paul’s Hospital Millennium Medical College\, Ethiopia\nPonsiano Ocama\, MBChB\, MMed\, PhD\, FCP(ECSA)\, Makerere University College of Health Sciences\, Uganda \n10:20 AM CAT\nWestern Africa | Role of Prolifica in Viral Hepatitis (Implementation & Research)\nGibril Ndow\, MD\, PhD\, Unit The Gambia at LSHTM\, The Gambia\nAlice Nanelin Guingané\, MD\, MPH\, Bogodogo University Hospital Center / University of Montpellier\, Burkina Faso / France \n10:30 AM CAT / SAST\nCentral Africa | Vertical Transmission\nChristian Tzeuton\, MD\, Douala Medical School / Société Camerounaise de Gastro-Entérologie\, Cameroon \n10:40 AM CAT / SAST\nSouthern Africa | Alcohol & Toxins\nWendy Spearman\, MBChB\, FCP\, FRCP\, MMed\, PhD\, University of Cape Town\, South Africa\nMark Sonderup\, B Pharm\, MBChB\, FCP(SA)\, MMed\, University of Cape Town\, South Africa\nSeadimo Gasennelwe-Gabakgore\, MD\, MPH\, Ministry of Health and Wellness\, Botswana \n10:50 AM CAT / SAST\nNorthern Africa | HCC\nManal Hamdy El-Sayed\, MD\, PhD\, Ain Shams University\, Egypt\nAshraf Omar\, MD\, MSc\, Cairo University\, Egypt\nNabil Debzi\, MD\, Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers\, Algeria \n11:00 AM CAT / SAST\nQ&A \n11:30 AM CAT / SAST\nClosure of Webinar \n 
URL:https://hepatology.ca/event/world-liver-awareness-day-webinar/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240411
DTEND;VALUE=DATE:20240412
DTSTAMP:20260416T204410
CREATED:20240218T203052Z
LAST-MODIFIED:20240318T174948Z
UID:3481-1712793600-1712879999@hepatology.ca
SUMMARY:Obesity Update Congress
DESCRIPTION:The inaugural Obesity Update (OU) congress is taking place on Thursday\, April 11\, 2024\, at the InterContinental Toronto Centre. Additional information about the congress can be found on the website at www.obesityupdate.ca.
URL:https://hepatology.ca/event/obesity-update-congress/
LOCATION:InterContinental Toronto Centre\, 225 Front Street West\, Toronto\, Ontario\, M5V 2X3\, Canada
CATEGORIES:In-Person,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240315
DTEND;VALUE=DATE:20240501
DTSTAMP:20260416T204410
CREATED:20240315T144325Z
LAST-MODIFIED:20240508T194211Z
UID:3515-1710460800-1714521599@hepatology.ca
SUMMARY:Online Opioid Self-Assessment Program (SAP)
DESCRIPTION:Improve your opioid prescribing skills with the Online Opioid SAP accredited by both the Royal College of Physicians and Surgeons of Canada and the College of Family Physicians of Canada. Engage with the latest Canadian Opioid Guideline through interactive case studies and personalized feedback. Funded by Health Canada and CGPA\, this not-for-profit program is your gateway to evidence-based opioid management. \nThis course is accredited as Section 3 for specialists (3 credits/hour) and Mainpro+ for Family Physicians (1 credit/hour). \nThe Online Opioid SAP is easily accessible\, highly interactive\, and it uses assessment as a technique for knowledge exchange and guideline implementation. To facilitate active learning\, various styles are employed\, including videos\, case presentations\, and an assortment of question types to keep you engaged and apply it in practice. \nSecure\, confidential\, and always seeking your feedback to improve healthcare practices. Join the Online Opioid SAP  at https://opioidassessment.ca/ and elevate your clinical expertise today. \n \n 
URL:https://hepatology.ca/event/online-opioid-self-assessment-program/
CATEGORIES:Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240221T120000
DTEND;TZID=America/Toronto:20240221T120000
DTSTAMP:20260416T204410
CREATED:20240218T201825Z
LAST-MODIFIED:20240218T202117Z
UID:3477-1708516800-1708516800@hepatology.ca
SUMMARY:Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension
DESCRIPTION:The Canadian Society of Palliative Care Physicians has partnered with the Pulmonary Hypertension Association of Canada to offer the webinar\, Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension\, on Feb 21st.  \nPalliative Care ECHO Project to offer targeted webinars to all physicians who treat patients with life-limiting illness. These sessions are accredited\, free and open to everyone.  \n \n  \nQuality of Life Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension \nWEDNESDAY\, February 21\, 2024TIME: 9 AM PT / 10 AM MT / 3 PM CT / 4 PM ET / 5 PM ATL / 5:30 PM NL \nHosted by the Canadian Society of Palliative Care Physicians (CSPCP) and Pulmonary Hypertension Association of Canada (PHA Canada) \nPresenters:    \nDr. David Christiansen\, MD FRCPC \nAssociate Professor and Co-Section Head\, Section of Respirology\, \nUniversity of Manitoba \nDr. Kirsten Wentlandt\, MD\, CCFP(PC)\, FRCPC\, PhD\, MHSc \nW. Gifford-Jones Professor in Pain Control and Palliative Care\, \nHead of the Division of Palliative Care\, University of Toronto \nTarget Audience: Physicians from across Canada \nDescription:Explore palliative care strategies for individuals with pulmonary hypertension (PH). We’ll delve into the disease course\, prognosis\, and impact on quality of life for patients with PH. Additionally\, we’ll examine the opportunities and challenges in providing palliative care to individuals facing this condition\, highlighting unique aspects as it relates to palliative care interventions. \nIn this session\, we will: \n\nreview disease course\, quality of life and prognosis of pulmonary hypertension (PH).\nreview opportunities and challenges in providing palliative care to patients with PH.\ndiscuss unique aspects of PH as it pertains to palliative care interventions.\n\n  \nECHO sessions are free to attend and open to any person with an interest in the topic; however\, the subject material is designed for physician audiences. \nAt the beginning of this session\, the speaker(s) will present a case\, which will be followed by a moderated and interactive discussion among participants. \nThe CSPCP Palliative Care Echo Sessions is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nCFPC members may claim 1 Mainpro+ Non-certified Group Learning credit
URL:https://hepatology.ca/event/quality-of-lift-matters-palliative-care-strategies/
LOCATION:Online
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR